loading
Aerovate Therapeutics Inc stock is traded at $2.63, with a volume of 8,440. It is down -0.75% in the last 24 hours and up +12.82% over the past month. Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. The initial focus of the company is on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.
See More
Previous Close:
$2.66
Open:
$2.65
24h Volume:
8,440
Relative Volume:
0.01
Market Cap:
$77.09M
Revenue:
-
Net Income/Loss:
$-75.52M
P/E Ratio:
-1.0115
EPS:
-2.6
Net Cash Flow:
$-56.92M
1W Performance:
+3.13%
1M Performance:
+12.82%
6M Performance:
-86.66%
1Y Performance:
-81.79%
1-Day Range:
Value
$2.60
$2.68
1-Week Range:
Value
$2.52
$2.715
52-Week Range:
Value
$1.25
$32.41

Aerovate Therapeutics Inc Stock (AVTE) Company Profile

Name
Name
Aerovate Therapeutics Inc
Name
Phone
617-443-2400
Name
Address
930 WINTER STREET, WALTHAM
Name
Employee
51
Name
Twitter
Name
Next Earnings Date
2024-08-12
Name
Latest SEC Filings
Name
AVTE's Discussions on Twitter

Compare AVTE with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
AVTE 2.64 77.09M 0 -75.52M -56.92M -2.60
VRTX 446.42 115.74B 10.63B -479.80M -1.35B 13.33
REGN 738.52 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 586.49 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.16 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.51 24.49B 3.30B -501.07M 1.03B 11.54

Aerovate Therapeutics Inc Stock (AVTE) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-01-23 Initiated Guggenheim Buy
Dec-06-22 Upgrade BTIG Research Neutral → Buy
Sep-19-22 Resumed Wedbush Outperform
Aug-16-22 Downgrade BTIG Research Buy → Neutral
Feb-11-22 Initiated BTIG Research Buy
Jul-26-21 Initiated Cowen Outperform
Jul-26-21 Initiated Evercore ISI Outperform
Jul-26-21 Initiated Jefferies Buy
Jul-26-21 Initiated Wedbush Outperform
View All

Aerovate Therapeutics Inc Stock (AVTE) Latest News

pulisher
Nov 17, 2024

GSA Capital Partners LLP Has $865,000 Stock Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - MarketBeat

Nov 17, 2024
pulisher
Nov 16, 2024

Short Interest in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Declines By 17.3% - MarketBeat

Nov 16, 2024
pulisher
Nov 16, 2024

Wedbush Research Analysts Raise Earnings Estimates for AVTE - Defense World

Nov 16, 2024
pulisher
Nov 15, 2024

What is Wedbush's Forecast for AVTE FY2024 Earnings? - MarketBeat

Nov 15, 2024
pulisher
Nov 12, 2024

Aerovate Therapeutics Reports Q3 Loss Amid Strategic Shift - TipRanks

Nov 12, 2024
pulisher
Nov 08, 2024

Finansavisen - Finansavisen

Nov 08, 2024
pulisher
Nov 05, 2024

Jade Biosciences’ Merger with Aerovate Therapeutics - Global Legal Chronicle

Nov 05, 2024
pulisher
Nov 05, 2024

INVESTOR ALERT: The M&A Class Action Firm Investigates the Merger of Aerovate Therapeutics, Inc. – AVTE - GlobeNewswire Inc.

Nov 05, 2024
pulisher
Nov 05, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATSG, STAF, AVTE on Behalf of Shareholders - Marketscreener.com

Nov 05, 2024
pulisher
Nov 04, 2024

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Air Transport Services Group, Inc. (Nasdaq– ATSG), Micropac Industries, Inc. (OTC – MPAD), Aerovate Therapeutics, Inc. (Nasdaq – AVTE), Outbrain Inc. (Nasd - ForexTV.com

Nov 04, 2024
pulisher
Nov 04, 2024

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Nov 04, 2024
pulisher
Nov 04, 2024

AEROVATE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerovate Therapeutics, Inc.AVTE - Marketscreener.com

Nov 04, 2024
pulisher
Nov 03, 2024

INVESTOR ALERT: The M&A Class Action Firm Investigates the Merger of Aerovate Therapeutics, Inc.AVTE - PR Newswire

Nov 03, 2024
pulisher
Nov 02, 2024

Aerovate Therapeutics Enters into Merger Agreement with Jade Biosciences - Defense World

Nov 02, 2024
pulisher
Nov 01, 2024

How Fairmount’s Paragon incubator steered two more companies to NASDAQ - BioCentury

Nov 01, 2024
pulisher
Nov 01, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE and PFIE on Behalf of Shareholders - Marketscreener.com

Nov 01, 2024
pulisher
Nov 01, 2024

Kuehn Law Encourages OB, AVTE, B, and MNTX Investors to Contact Law Firm - The Malaysian Reserve

Nov 01, 2024
pulisher
Oct 31, 2024

SEC Form 425 filed by Aerovate Therapeutics Inc. - Quantisnow

Oct 31, 2024
pulisher
Oct 31, 2024

Form 425 Aerovate Therapeutics, Filed by: Aerovate Therapeutics, Inc. - StreetInsider.com

Oct 31, 2024
pulisher
Oct 31, 2024

Aerovate (AVTE) Shares Rally As Market Responds To A Merger Agreement - Stocks Telegraph

Oct 31, 2024
pulisher
Oct 31, 2024

Jade, another biotech spinout of Paragon, to merge with Aerovate - BioPharma Dive

Oct 31, 2024
pulisher
Oct 31, 2024

Jade Biosciences and Aerovate announce merger deal - Investing.com

Oct 31, 2024
pulisher
Oct 31, 2024

AVTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aerovate Therapeutics, Inc. Is Fair to Shareholders - Business Wire

Oct 31, 2024
pulisher
Oct 31, 2024

Aerovate to Merge With Jade Biosciences, Pursue Kidney Treatment - MarketWatch

Oct 31, 2024
pulisher
Oct 31, 2024

Shareholder Alert: Ademi LLP Investigates Whether Aerovate Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Business Wire

Oct 31, 2024
pulisher
Oct 31, 2024

Aerovate climbs on all-stock merger deal with Jade - MSN

Oct 31, 2024
pulisher
Oct 31, 2024

Aerovate stock rises on all-stock merger deal (AVTE:NASDAQ) - Seeking Alpha

Oct 31, 2024
pulisher
Oct 31, 2024

Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement - GlobeNewswire

Oct 31, 2024
pulisher
Oct 28, 2024

Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Down 21.4% in October - MarketBeat

Oct 28, 2024
pulisher
Oct 17, 2024

Aerovate Therapeutics regains Nasdaq compliance - Investing.com India

Oct 17, 2024
pulisher
Oct 17, 2024

Aerovate Therapeutics regains Nasdaq compliance By Investing.com - Investing.com Canada

Oct 17, 2024
pulisher
Oct 17, 2024

Hypertension Clinical Trials 2024: FDA Approvals, Medication, Therapies, MOA, ROA, Companies by DelveInsight | Quantum Genomics, CinCor Pharma, Mineralys Therapeutics, Alnylam Therapeutics, Novartis - The Globe and Mail

Oct 17, 2024
pulisher
Oct 17, 2024

Cubist Systematic Strategies LLC Makes New Investment in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Oct 17, 2024
pulisher
Oct 14, 2024

Analyzing Aerovate Therapeutics Inc (AVTE) After Recent Trading Activity - Knox Daily

Oct 14, 2024
pulisher
Oct 13, 2024

Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Update - MarketBeat

Oct 13, 2024
pulisher
Oct 10, 2024

Aerovate Therapeutics announces board member resignation - Investing.com India

Oct 10, 2024
pulisher
Oct 10, 2024

Aerovate Therapeutics announces board member resignation By Investing.com - Investing.com UK

Oct 10, 2024
pulisher
Oct 03, 2024

XTX Topco Ltd Invests $35,000 in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Oct 03, 2024
pulisher
Sep 28, 2024

Short Interest in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Decreases By 15.7% - MarketBeat

Sep 28, 2024
pulisher
Sep 28, 2024

Bank of New York Mellon Corp Increases Stake in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Sep 28, 2024
pulisher
Sep 26, 2024

Deerfield Management Company L.P. Series C Takes Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Sep 26, 2024
pulisher
Sep 26, 2024

Deerfield Management Company L.P. Series C Acquires New Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - MarketBeat

Sep 26, 2024
pulisher
Sep 25, 2024

Affinity Asset Advisors LLC Makes New $332,000 Investment in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Sep 25, 2024
pulisher
Sep 24, 2024

Market Highlights: Alector Inc (ALEC) Ends on a Low Note at 5.45 - The Dwinnex

Sep 24, 2024
pulisher
Sep 24, 2024

AlgoTx completes pivotal phase 2 trial for ground-breaking CIPN treatment - PharmaTimes

Sep 24, 2024
pulisher
Sep 23, 2024

Why AeroVironment Shares Are Flying Higher Today - sharewise

Sep 23, 2024
pulisher
Sep 23, 2024

Alector (NASDAQ:ALEC) Shares Down 5.6% - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Defense Stock Soars on ‘Rare Move’ From the U.S. Army - Barron's

Sep 23, 2024
pulisher
Sep 23, 2024

AeroVironment (NASDAQ:AVAV) Shares Gap Up to $182.76 - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

AeroVironment Stock Is Rising Monday: What's Driving The Action? - Benzinga

Sep 23, 2024
pulisher
Sep 23, 2024

Altitude Group’s AGM: Mixed Shareholder Decisions - TipRanks

Sep 23, 2024

Aerovate Therapeutics Inc Stock (AVTE) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Cap:     |  Volume (24h):